Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis: A Randomized, Placebo-phase Trial

OBJECTIVE: To assess the safety and efficacy of rituximab in a randomized, double-blind, placebo-phase, trial of adult and pediatric myositis. METHODS: Adults with refractory polymyositis and adults and children with refractory dermatomyositis were enrolled. Entry criteria included muscle weakness a...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Oddis, Chester V., Reed, Ann M., Aggarwal, Rohit, Rider, Lisa G., Ascherman, Dana P., Levesque, Marc C., Barohn, Richard J., Feldman, Brian M., Harris-Love, Michael O., Koontz, Diane C., Fertig, Noreen, Kelley, Stephanie S., Pryber, Sherrie L., Miller, Frederick W., Rockette, Howard E.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2013
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3558563/
https://ncbi.nlm.nih.gov/pubmed/23124935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.37754
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन